ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
4,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
4,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4,4,Application site scab,Application site reactions,Administration site reactions,Genrl,N
4,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
5,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
5,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
5,4,Application site scab,Application site reactions,Administration site reactions,Genrl,N
5,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
6,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
6,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
6,3,Headache,Headaches NEC,Headaches,Nerv,N
6,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
6,5,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
6,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
7,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
8,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,2,Headache,Headaches NEC,Headaches,Nerv,N
10,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
10,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
10,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
10,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,1,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
11,2,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
11,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
12,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,1,Atypical fibroxanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
13,2,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
13,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
14,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
14,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
14,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
15,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
16,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
16,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
16,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
16,4,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
16,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
16,6,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
17,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
17,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
18,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
18,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
18,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
19,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
19,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
20,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
20,2,Tumour ulceration,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
21,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
21,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
21,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
21,4,Headache,Headaches NEC,Headaches,Nerv,N
21,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
21,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
23,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
23,2,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
23,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
24,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
24,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
25,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
26,2,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
27,1,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
27,2,Trigeminal nerve paresis,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
28,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
28,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
29,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
29,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
30,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
30,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
30,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
30,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
30,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
30,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
30,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
30,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
31,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
32,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
32,2,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
32,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
32,4,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
32,5,Application site pain,Application site reactions,Administration site reactions,Genrl,N
32,6,Application site scab,Application site reactions,Administration site reactions,Genrl,N
32,7,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
32,8,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
32,9,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
32,10,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
32,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,12,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
32,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
32,14,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
32,15,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
32,16,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,17,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
32,18,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
32,19,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
33,2,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
33,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
33,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
34,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
34,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
35,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
35,3,Headache,Headaches NEC,Headaches,Nerv,N
35,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
36,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
36,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,3,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
37,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
37,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
37,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
37,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
39,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
39,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
39,4,Headache,Headaches NEC,Headaches,Nerv,N
39,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
39,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
39,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
40,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
40,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
41,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
41,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
42,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
42,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
42,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
42,4,Headache,Headaches NEC,Headaches,Nerv,N
42,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,1,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
43,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
43,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
43,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
44,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
44,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
44,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
45,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
46,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
47,1,Facial nerve disorder,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
47,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
48,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
48,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
48,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
48,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
49,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
49,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
49,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
50,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
50,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
51,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
51,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
51,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
51,5,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
51,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
52,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
52,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
52,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
53,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
53,2,Headache,Headaches NEC,Headaches,Nerv,N
54,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
54,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
54,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
54,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
54,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
54,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
55,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
55,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
56,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
56,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
56,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
57,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
57,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
57,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
58,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
58,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
59,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
61,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
61,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
62,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
62,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
62,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
62,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
62,5,Headache,Headaches NEC,Headaches,Nerv,N
62,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
63,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
64,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
65,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
65,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
66,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
66,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
66,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
67,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
67,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
67,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
67,4,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,5,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
68,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
68,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
68,3,Headache,Headaches NEC,Headaches,Nerv,N
68,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
69,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
69,4,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
69,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
70,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
70,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
70,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
70,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
71,2,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
72,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
72,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
73,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
73,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
73,3,Toxic dilatation of intestine,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
73,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
74,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
74,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
74,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
75,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
75,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
75,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
75,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
77,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
77,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
77,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
77,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
77,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
77,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
78,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
80,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
80,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
81,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
81,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
82,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
82,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
82,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
83,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
83,2,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
83,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
83,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,5,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
84,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
84,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
85,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
85,2,Application site pustules,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
85,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
85,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
86,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
86,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
86,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
86,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
86,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
87,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
87,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
89,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
89,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
89,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
89,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
90,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
90,2,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
90,3,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
90,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
90,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
90,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
90,7,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,8,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
90,9,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
90,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
91,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
92,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
93,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
94,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
95,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
95,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
95,3,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
96,1,Headache,Headaches NEC,Headaches,Nerv,N
96,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
96,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
97,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
97,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
97,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
97,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
98,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
98,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,1,Application site scab,Application site reactions,Administration site reactions,Genrl,N
99,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
99,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
99,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
99,5,Headache,Headaches NEC,Headaches,Nerv,N
99,6,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
99,7,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
99,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
99,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
99,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
99,11,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
100,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
100,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
100,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
100,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
100,5,Headache,Headaches NEC,Headaches,Nerv,N
100,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
101,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
101,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
101,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
101,5,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,6,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
101,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
102,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
102,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
102,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
103,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
104,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
104,2,Headache,Headaches NEC,Headaches,Nerv,N
104,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
104,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
104,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
106,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
107,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
107,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
108,1,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
109,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
109,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
109,3,Headache,Headaches NEC,Headaches,Nerv,N
110,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
110,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
111,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
111,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
112,1,Administration site discharge,Administration site reactions NEC,Administration site reactions,Genrl,N
112,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
112,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
112,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
112,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
112,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,7,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,8,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,9,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,11,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
113,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
113,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
113,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
114,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
114,2,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
114,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
114,4,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
114,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
115,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
115,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
115,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
115,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
116,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
117,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
117,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
117,3,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
118,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
119,1,Headache,Headaches NEC,Headaches,Nerv,N
119,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
119,3,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
119,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
120,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
120,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
120,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
120,4,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
120,5,Application site pain,Application site reactions,Administration site reactions,Genrl,N
120,6,Application site scab,Application site reactions,Administration site reactions,Genrl,N
120,7,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
120,8,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
121,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
121,2,Urethritis noninfective,Urethral infections and inflammations,Urethral disorders (excl calculi),Renal,N
122,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
123,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
124,2,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
124,3,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
124,4,Application site mass,Application site reactions,Administration site reactions,Genrl,N
124,5,Application site scab,Application site reactions,Administration site reactions,Genrl,N
124,6,Application site scar,Application site reactions,Administration site reactions,Genrl,N
124,7,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
124,8,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
125,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
126,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
126,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
127,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
127,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
127,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
127,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
128,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
128,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
129,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
130,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
130,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
130,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
130,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
131,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
131,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
131,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
131,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
131,5,Headache,Headaches NEC,Headaches,Nerv,N
131,6,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
131,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
131,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
131,9,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
131,10,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
131,12,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
131,13,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,14,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
132,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
132,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
133,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
133,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
133,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
133,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
134,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
134,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
135,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
135,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
135,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
135,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
135,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
136,1,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
137,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
138,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
138,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
138,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
138,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
138,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
139,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
139,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
140,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
140,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
140,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
140,4,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
141,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
142,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
143,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
143,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
144,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
145,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
145,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
146,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
146,2,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
147,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
148,1,Headache,Headaches NEC,Headaches,Nerv,N
149,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
149,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
149,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
150,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
151,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
151,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
151,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
152,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
152,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
152,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
153,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
153,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
154,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
155,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
155,2,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
155,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
155,4,Headache,Headaches NEC,Headaches,Nerv,N
155,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
155,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
155,8,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
155,9,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
156,1,Application site discharge,Application site reactions,Administration site reactions,Genrl,N
156,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
156,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
156,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
157,1,Allergic keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
157,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
157,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
158,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
158,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
158,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
158,4,Headache,Headaches NEC,Headaches,Nerv,N
158,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
158,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
158,7,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
159,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
160,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
160,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
160,3,Headache,Headaches NEC,Headaches,Nerv,N
160,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
160,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
160,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
160,7,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
160,8,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
161,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
161,2,Headache,Headaches NEC,Headaches,Nerv,N
161,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
161,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
161,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
162,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
162,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
162,3,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
163,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
164,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
164,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
164,3,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
164,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
165,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
165,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
165,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
166,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
166,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
168,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
168,2,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
169,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
170,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
171,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
172,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
173,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
174,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
174,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,3,Psychological trauma,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
174,4,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
175,1,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
175,2,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
175,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
175,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
175,5,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
175,6,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
176,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
177,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
177,2,Skin neoplasm excision,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
178,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
178,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
178,3,Product confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
179,1,Skin cancer metastatic,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
180,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
